Multifaceted genomic risk for brain function in schizophrenia

[1]  Yasushi Kishimoto,et al.  A Role for Myosin Va in Cerebellar Plasticity and Motor Learning: A Possible Mechanism Underlying Neurological Disorder in Myosin Va Disease , 2011, The Journal of Neuroscience.

[2]  V. Calhoun,et al.  Antipsychotic dose and diminished neural modulation: A multi-site fMRI study , 2011, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

[3]  Vince D. Calhoun,et al.  A pilot multivariate parallel ICA study to investigate differential linkage between neural networks and genetic profiles in schizophrenia , 2010, NeuroImage.

[4]  J. Duan,et al.  Genome-wide approaches to schizophrenia , 2010, Brain Research Bulletin.

[5]  A. Morris,et al.  Data quality control in genetic case-control association studies , 2010, Nature Protocols.

[6]  Daniel R Weinberger,et al.  Common genetic variation in Neuregulin 3 (NRG3) influences risk for schizophrenia and impacts NRG3 expression in human brain , 2010, Proceedings of the National Academy of Sciences.

[7]  Vince D. Calhoun,et al.  Identification of Imaging Biomarkers in Schizophrenia: A Coefficient-constrained Independent Component Analysis of the Mind Multi-site Schizophrenia Study , 2010, Neuroinformatics.

[8]  D. Kullmann.  Neurological channelopathies. , 2010, Annual review of neuroscience.

[9]  Muriel Walshe,et al.  Epistasis between the DAT 3′ UTR VNTR and the COMT Val158Met SNP on cortical function in healthy subjects and patients with schizophrenia , 2009, Proceedings of the National Academy of Sciences.

[10]  P. Visscher,et al.  Common polygenic variation contributes to risk of schizophrenia and bipolar disorder , 2009, Nature.

[11]  M. Minzenberg,et al.  Meta-analysis of 41 functional neuroimaging studies of executive function in schizophrenia. , 2009, Archives of general psychiatry.

[12]  P. Fitzgerald,et al.  Superior temporal gyrus volume change in schizophrenia: A review on Region of Interest volumetric studies , 2009, Brain Research Reviews.

[13]  V. Calhoun,et al.  Combining fMRI and SNP data to investigate connections between brain function and genetics using parallel ICA , 2009, Human brain mapping.

[14]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[15]  Jingyu Liu,et al.  A multimodality ICA study - integrating genomic single nucleotide polymorphisms with functional neuroimaging data , 2008, 2008 IEEE International Conference on Bioinformatics and Biomeidcine Workshops.

[16]  E. Bullmore,et al.  Meta-Analysis of Gray Matter Anomalies in Schizophrenia: Application of Anatomic Likelihood Estimation and Network Analysis , 2008, Biological Psychiatry.

[17]  John P A Ioannidis,et al.  Systematic meta-analyses and field synopsis of genetic association studies in schizophrenia: the SzGene database , 2008, Nature Genetics.

[18]  E. Walker,et al.  Longitudinal progression of movement abnormalities in relation to psychotic symptoms in adolescents at high risk of schizophrenia. , 2008, Archives of general psychiatry.

[19]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[20]  Guoping Feng,et al.  The Histone Deacetylase HDAC4 Connects Neural Activity to Muscle Transcriptional Reprogramming* , 2007, Journal of Biological Chemistry.

[21]  Tülay Adali,et al.  Estimating the number of independent components for functional magnetic resonance imaging data , 2007, Human brain mapping.

[22]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[23]  Roberto Malinow,et al.  The Neuregulin-1 Receptor ErbB4 Controls Glutamatergic Synapse Maturation and Plasticity , 2007, Neuron.

[24]  T. Gao,et al.  Neuregulin-1 Enhances Depolarization-Induced GABA Release , 2007, Neuron.

[25]  Michael B. Mayhew,et al.  Allelic variation in GAD1 (GAD67) is associated with schizophrenia and influences cortical function and gene expression , 2007, Molecular Psychiatry.

[26]  Murat Yücel,et al.  Task-induced deactivation of midline cortical regions in schizophrenia assessed with fMRI , 2007, Schizophrenia Research.

[27]  D. Reich,et al.  Principal components analysis corrects for stratification in genome-wide association studies , 2006, Nature Genetics.

[28]  E. Bramon,et al.  Regional brain morphometry in patients with schizophrenia or bipolar disorder and their unaffected relatives. , 2006, The American journal of psychiatry.

[29]  K. Hugdahl,et al.  MR MORPHOMETRY ANALYSIS OF GREY MATTER VOLUME REDUCTION IN SCHIZOPHRENIA: ASSOCIATION WITH HALLUCINATIONS , 2006, The International journal of neuroscience.

[30]  H. Tanila,et al.  Cortical glutamate–dopamine interaction and ketamine-induced psychotic symptoms in man , 2005, Psychopharmacology.

[31]  R. Woods,et al.  Cortical Thinning in Cingulate and Occipital Cortices in First Episode Schizophrenia , 2005, Biological Psychiatry.

[32]  A. Addington,et al.  The neurodevelopmental model of schizophrenia: update 2005 , 2005, Molecular Psychiatry.

[33]  R. Woods,et al.  Mapping cortical thickness and gray matter concentration in first episode schizophrenia. , 2005, Cerebral cortex.

[34]  W. Honer,et al.  Extrapyramidal symptoms and signs in first-episode, antipsychotic exposed and non-exposed patients with schizophrenia or related psychotic illness , 2005, Journal of psychopharmacology.

[35]  Kent A. Kiehl,et al.  Abnormal hemodynamics in schizophrenia during an auditory oddball task , 2005, Biological Psychiatry.

[36]  V. Calhoun,et al.  Voxel-based morphometry versus region of interest: a comparison of two methods for analyzing gray matter differences in schizophrenia , 2005, Schizophrenia Research.

[37]  Yusuke Nakamura,et al.  Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis , 2003, Nature Genetics.

[38]  S. Lawrie,et al.  Structural and Functional Abnormalities of the Amygdala in Schizophrenia , 2003, Annals of the New York Academy of Sciences.

[39]  I. Gottesman,et al.  The endophenotype concept in psychiatry: etymology and strategic intentions. , 2003, The American journal of psychiatry.

[40]  Marianna D. Eddy,et al.  Regionally localized thinning of the cerebral cortex in schizophrenia , 2003, Schizophrenia Research.

[41]  Paul J. Harrison,et al.  For Personal Use. Only Reproduce with Permission from the Lancet Publishing Group. Genes for Schizophrenia? Recent Findings and Their Pathophysiological Implications , 2022 .

[42]  Jean-Francois Mangin,et al.  What is the best similarity measure for motion correction in fMRI time series? , 2002, IEEE Transactions on Medical Imaging.

[43]  R. Scheller,et al.  Amisyn, a Novel Syntaxin-binding Protein That May Regulate SNARE Complex Assembly* , 2002, The Journal of Biological Chemistry.

[44]  Gregory G. Brown,et al.  Parietal dysfunction is associated with increased outcome-related decision-making in schizophrenia patients , 2002, Biological Psychiatry.

[45]  L. Freire,et al.  Motion Correction Algorithms May Create Spurious Brain Activations in the Absence of Subject Motion , 2001, NeuroImage.

[46]  S Kawahara,et al.  Classical eyeblink conditioning in glutamate receptor subunit δ2 mutant mice is impaired in the delay paradigm but not in the trace paradigm , 2001, The European journal of neuroscience.

[47]  Yogesh K. Dwivedi,et al.  Decrease in reelin and glutamic acid decarboxylase67 (GAD67) expression in schizophrenia and bipolar disorder: a postmortem brain study. , 2000, Archives of general psychiatry.

[48]  R. Murray,et al.  Functional anatomy of auditory verbal imagery in schizophrenic patients with auditory hallucinations. , 2000, The American journal of psychiatry.

[49]  J. Lieberman,et al.  Neuropsychology of first-episode schizophrenia: initial characterization and clinical correlates. , 2000, The American journal of psychiatry.

[50]  I. Gottesman,et al.  Twin studies of schizophrenia: from bow-and-arrow concordances to star wars Mx and functional genomics. , 2000, American journal of medical genetics.

[51]  A. Sampson,et al.  Decreased glutamic acid decarboxylase67 messenger RNA expression in a subset of prefrontal cortical gamma-aminobutyric acid neurons in subjects with schizophrenia. , 2000, Archives of general psychiatry.

[52]  D Hell,et al.  Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans. , 2000, Journal of psychiatric research.

[53]  S. Kiebel,et al.  Detecting Structural Changes in Whole Brain Based on Nonlinear Deformations—Application to Schizophrenia Research , 1999, NeuroImage.

[54]  Lothar R. Schad,et al.  Motor Dysfunction and Sensorimotor Cortex Activation Changes in Schizophrenia: A Study with Functional Magnetic Resonance Imaging , 1999, NeuroImage.

[55]  M. Schulzer,et al.  At issue: schizophrenia and rheumatoid arthritis: the negative association revisited. , 1999, Schizophrenia bulletin.

[56]  A. Goodman.  Three independent lines of evidence suggest retinoids as causal to schizophrenia. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[57]  Michael D. Nelson,et al.  Hippocampal volume reduction in schizophrenia as assessed by magnetic resonance imaging : A meta-analytic study , 1998 .

[58]  F. Ebner,et al.  Brain protein phosphatase 2A: Developmental regulation and distinct cellular and subcellular localization by B subunits , 1998, The Journal of comparative neurology.

[59]  R. Gur,et al.  Mesolimbic dopamine D3 receptors and use of antipsychotics in patients with schizophrenia. A postmortem study. , 1997, Archives of general psychiatry.

[60]  M. First,et al.  Structured clinical interview for DSM-IV axis II personality disorders : SCID-II , 1997 .

[61]  R. V. Omkumar,et al.  Identification of a Phosphorylation Site for Calcium/Calmodulindependent Protein Kinase II in the NR2B Subunit of the N-Methyl-D-aspartate Receptor* , 1996, The Journal of Biological Chemistry.

[62]  K. Funabiki,et al.  Retarded vestibular compensation in mutant mice deficient in δ2 glutamate receptor subunit , 1995 .

[63]  Terrence J. Sejnowski,et al.  An Information-Maximization Approach to Blind Separation and Blind Deconvolution , 1995, Neural Computation.

[64]  L. Schad,et al.  Sensorimotor Cortex and Supplementary Motor Area Changes in Schizophrenia , 1995, British Journal of Psychiatry.

[65]  E. G. Jones,et al.  Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. , 1995, Archives of general psychiatry.

[66]  新保 信子.  Impairment of motor coordination, Purkinje cell synapse formation and cerebellar long-term depression in GluRδ2 mutant mice , 1995 .

[67]  K. Funabiki,et al.  Retarded vestibular compensation in mutant mice deficient in delta 2 glutamate receptor subunit. , 1995, Neuroreport.

[68]  Karl J. Friston,et al.  Spatial registration and normalization of images , 1995 .

[69]  T. McGlashan,et al.  Risk factors for spontaneous dyskinesia in schizophrenia. , 1994, Archives of general psychiatry.

[70]  E. Walker,et al.  Neuromotor precursors of schizophrenia. , 1994, Schizophrenia bulletin.

[71]  N C Andreasen,et al.  The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assessing diagnosis and psychopathology. , 1992, Archives of general psychiatry.

[72]  N. Andreasen.  The Scale for the Assessment of Negative Symptoms (SANS): Conceptual and Theoretical Foundations , 1989, British Journal of Psychiatry.

[73]  J. Shields,et al.  A polygenic theory of schizophrenia. , 1972, Proceedings of the National Academy of Sciences of the United States of America.